NanoEntek, Inc. (KOSDAQ:039860)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,930.00
+155.00 (4.11%)
At close: Jul 27, 2026
Market Cap149.71B +32.5%
Revenue (ttm)40.66B +27.7%
Net Income2.65B -21.9%
EPS75.61 -30.4%
Shares Out 38.09M
PE Ratio51.98
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,700,666
Open3,875.00
Previous Close3,775.00
Day's Range3,775.00 - 4,235.00
52-Week Range3,015.00 - 9,390.00
Beta0.72
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About NanoEntek

NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a residual white blood cell counters; ADAMII/fluorescence stem cell counter; fluorescence cell counters and cell analyzers; brightfield cell counters; somatic... [Read more]

Industry Laboratory Analytical Instruments
Founded 1987
Employees 97
Stock Exchange KOSDAQ
Ticker Symbol 039860
Full Company Profile

Financial Performance

In 2025, NanoEntek's revenue was 38.13 billion, an increase of 25.16% compared to the previous year's 30.46 billion. Earnings were 1.58 billion, a decrease of -55.93%.

Financial Statements